Agency for Healthcare Research & Quality

Dear Research Advocate:

The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’€™t accounted for that way on the federal books. The arguments we’€™ve been making are now further bolstered by the BEA’€™s decision. Spread the word!

Last week, a briefing sponsored by the Friends of VA Medical Care and Health Research (FOVA) brought the Department of Veterans Affairs (VA) Research and Development program to Capitol Hill.  Two researchers ’€“ John McQuaid, Ph.D., of San Francisco VA Medical Center and Daniel Gottlieb, M.D., M.P.H., of VA Boston Healthcare System ’€“ shared their work to advance health outcomes for veterans.   The topics discussed varied, including substance abuse, phantom pain, depression, and sleep apnea, and represented just a small fraction of the research con

The August congressional recess is here! Members of Congress are back home for the month long break. Now’€™s the time to speak up and urge policy makers to make research for health a higher national priority before they return to Capitol Hill and make decisions that will affect the health and prosperity of our nation. Join Research!America’€™s social media congressional recess campaign, Medical Research is at Risk. We Need Cures, Not Cuts!

Dear Research Advocate:

We NEED CURES, NOT CUTS

Sequestration’€™s arbitrary, across-the-board budget cuts to defense and non-defense spending have ravaged (and will continue to ravage) our research enterprise. Sequestration and the inability of Congress to pass a budget will dramatically reduce funding for medical research and critical public health functions for years to come. Funding cuts are stopping highly promising research in its tracks, squandering exciting new potential for treatments and cures for millions of Americans who are waiting for them.

Dear Research Advocate:

From advances in diabetes research to record approval of drugs to treat rare diseases, taxpayer funded research and the effective employment of regulatory tools played a significant role in improving the health and wellbeing of Americans in 2014.

Dear Research Advocate:

The tiny increases included in the “Cromnibus” bill for the National Institutes of Health (NIH) and our nation’s other health research agencies are just that. The underwhelming support for the NIH, the Centers for Disease Control and Prevention, the National Science Foundation and the Food and Drug Administration following years of stagnant funding and budget cuts begs the question – how low can we go, given health threats the likes of which stand to bankrupt the nation?

Dear Research Advocate:

A continuing resolution to fund the federal government at just under Fiscal Year 2014 levels – it now includes supplemental funding to help combat the escalating Ebola epidemic – is on its way to the President’€™s desk, and members of Congress will soon be on their way home. Where does that leave us? At the very least, with something to talk about.

Pages

Subscribe to RSS - Agency for Healthcare Research & Quality